Author

Michael Harry Barnett

The University of SydneyORCID 0000-0002-2156-8864Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:differential expression· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Alessandra LugaresiiD· 1 shared Alexandre PratiD· 1 shared Allan G. KermodeiD· 1 shared Allan MotyeriD· 1 shared Anneke van der WaltiD· 1 shared Attila SasiD· 1 shared Bhim Sen SinghaliD· 1 shared Bicheng YangiD· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alessandra LugaresiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The mutational landscape of single neurons and oligodendrocytes reveals evidence of inflammation-associated DNA damage in multiple sclerosis

Allan Motyer, Stacey Jackson, Bicheng Yang, Ivon Harliwong, Wei Tian, Wingin Shiu, Yunchang Shao, Bo Wang, Catriona McLean, Michael Harry Barnett, Trevor John Kilpatrick, Stephen Leslie, Justin P. Rubio

The paper analyzes somatic mutations in neurons and oligodendrocytes from MS patients, finding increased DNA damage linked to inflammation.

bioRxiv · Apr 30, 2022 · PreprintGenomics

Immunotherapy prevents long-term disability in relapsing multiple sclerosis over 15 years

Tomáš Kalinčík, Sifat Sharmin, Charles Benjamin Malpas, Tim D. Spelman, Dana Horáková, Eva Havrdová, María Trojano, Guillermo Izquierdo, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Vilija Jokubaitis, Anneke van der Walt, , on behalf of the MSBase Study group

This study shows that immunotherapy reduces disability and relapses in relapsing multiple sclerosis over 15 years.

bioRxiv · Aug 23, 2019 · PreprintNeuroscience